These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
204 related articles for article (PubMed ID: 24597649)
1. Critical role of the endogenous interferon ligand-receptors in type I and type II interferons response. Lasfar A; Cook JR; Cohen Solal KA; Reuhl K; Kotenko SV; Langer JA; Laskin DL Immunology; 2014 Jul; 142(3):442-52. PubMed ID: 24597649 [TBL] [Abstract][Full Text] [Related]
2. Casein Kinase 1α Mediates the Degradation of Receptors for Type I and Type II Interferons Caused by Hemagglutinin of Influenza A Virus. Xia C; Wolf JJ; Vijayan M; Studstill CJ; Ma W; Hahm B J Virol; 2018 Apr; 92(7):. PubMed ID: 29343571 [TBL] [Abstract][Full Text] [Related]
3. An IRF-3-, IRF-5-, and IRF-7-Independent Pathway of Dengue Viral Resistance Utilizes IRF-1 to Stimulate Type I and II Interferon Responses. Carlin AF; Plummer EM; Vizcarra EA; Sheets N; Joo Y; Tang W; Day J; Greenbaum J; Glass CK; Diamond MS; Shresta S Cell Rep; 2017 Nov; 21(6):1600-1612. PubMed ID: 29117564 [TBL] [Abstract][Full Text] [Related]
4. Neuronal Ablation of Alpha/Beta Interferon (IFN-α/β) Signaling Exacerbates Central Nervous System Viral Dissemination and Impairs IFN-γ Responsiveness in Microglia/Macrophages. Hwang M; Bergmann CC J Virol; 2020 Sep; 94(20):. PubMed ID: 32796063 [TBL] [Abstract][Full Text] [Related]
5. Localization of a receptor nonapeptide with a possible role in the binding of the type I interferons. Eid P; Langer JA; Bailly G; Lejealle R; Guymarho J; Tovey MG Eur Cytokine Netw; 2000 Dec; 11(4):560-73. PubMed ID: 11125298 [TBL] [Abstract][Full Text] [Related]
6. Type I Interferon Signaling Is Required for CpG-Oligodesoxynucleotide-Induced Control of Schleicher U; Liese J; Justies N; Mischke T; Haeberlein S; Sebald H; Kalinke U; Weiss S; Bogdan C Front Immunol; 2018; 9():79. PubMed ID: 29459858 [TBL] [Abstract][Full Text] [Related]
7. Identification of residues of the IFNAR1 chain of the type I human interferon receptor critical for ligand binding and biological activity. Cajean-Feroldi C; Nosal F; Nardeux PC; Gallet X; Guymarho J; Baychelier F; Sempé P; Tovey MG; Escary JL; Eid P Biochemistry; 2004 Oct; 43(39):12498-512. PubMed ID: 15449939 [TBL] [Abstract][Full Text] [Related]
8. Evidence for the involvement of type I interferon in pulmonary arterial hypertension. George PM; Oliver E; Dorfmuller P; Dubois OD; Reed DM; Kirkby NS; Mohamed NA; Perros F; Antigny F; Fadel E; Schreiber BE; Holmes AM; Southwood M; Hagan G; Wort SJ; Bartlett N; Morrell NW; Coghlan JG; Humbert M; Zhao L; Mitchell JA Circ Res; 2014 Feb; 114(4):677-88. PubMed ID: 24334027 [TBL] [Abstract][Full Text] [Related]
9. The interdependent, overlapping, and differential roles of type I and II IFNs in the pathogenesis of experimental autoimmune encephalomyelitis. Naves R; Singh SP; Cashman KS; Rowse AL; Axtell RC; Steinman L; Mountz JD; Steele C; De Sarno P; Raman C J Immunol; 2013 Sep; 191(6):2967-77. PubMed ID: 23960239 [TBL] [Abstract][Full Text] [Related]
10. The IFNAR1 subunit of the type I IFN receptor complex contains a functional nuclear localization sequence. Subramaniam PS; Johnson HM FEBS Lett; 2004 Dec; 578(3):207-10. PubMed ID: 15589821 [TBL] [Abstract][Full Text] [Related]
11. Human interferon-ϵ and interferon-κ exhibit low potency and low affinity for cell-surface IFNAR and the poxvirus antagonist B18R. Harris BD; Schreiter J; Chevrier M; Jordan JL; Walter MR J Biol Chem; 2018 Oct; 293(41):16057-16068. PubMed ID: 30171073 [TBL] [Abstract][Full Text] [Related]
12. IFNAR2 Is Required for Anti-influenza Immunity and Alters Susceptibility to Post-influenza Bacterial Superinfections. Shepardson KM; Larson K; Johns LL; Stanek K; Cho H; Wellham J; Henderson H; Rynda-Apple A Front Immunol; 2018; 9():2589. PubMed ID: 30473701 [TBL] [Abstract][Full Text] [Related]
13. Multifaceted activities of type I interferon are revealed by a receptor antagonist. Levin D; Schneider WM; Hoffmann HH; Yarden G; Busetto AG; Manor O; Sharma N; Rice CM; Schreiber G Sci Signal; 2014 May; 7(327):ra50. PubMed ID: 24866020 [TBL] [Abstract][Full Text] [Related]
14. Toll-like receptor 7-mediated type I interferon signaling prevents cholestasis- and hepatotoxin-induced liver fibrosis. Roh YS; Park S; Kim JW; Lim CW; Seki E; Kim B Hepatology; 2014 Jul; 60(1):237-49. PubMed ID: 24375615 [TBL] [Abstract][Full Text] [Related]
15. Lymphatic Type 1 Interferon Responses Are Critical for Control of Systemic Reovirus Dissemination. Phillips MB; Dina Zita M; Howells MA; Weinkopff T; Boehme KW J Virol; 2021 Jan; 95(4):. PubMed ID: 33208448 [TBL] [Abstract][Full Text] [Related]
16. Both Type I and Type II Interferons Can Activate Antitumor M1 Macrophages When Combined With TLR Stimulation. Müller E; Speth M; Christopoulos PF; Lunde A; Avdagic A; Øynebråten I; Corthay A Front Immunol; 2018; 9():2520. PubMed ID: 30450098 [TBL] [Abstract][Full Text] [Related]
17. Comprehensive comparison of thirteen kinds of cytokine receptors from the endangered fish Chinese sturgeon (Acipenser sinensis). Xu Q; Deng D; Guo H; Yuan H; Zhang W; Wang B; Lu Y; Chen D; Zhang S Dev Comp Immunol; 2021 Oct; 123():104132. PubMed ID: 34038788 [TBL] [Abstract][Full Text] [Related]
18. Type I interferons protect from Toll-like receptor 9-associated liver injury and regulate IL-1 receptor antagonist in mice. Petrasek J; Dolganiuc A; Csak T; Kurt-Jones EA; Szabo G Gastroenterology; 2011 Feb; 140(2):697-708.e4. PubMed ID: 20727895 [TBL] [Abstract][Full Text] [Related]
19. Functional crosstalk between type I and II interferon through the regulated expression of STAT1. Gough DJ; Messina NL; Hii L; Gould JA; Sabapathy K; Robertson AP; Trapani JA; Levy DE; Hertzog PJ; Clarke CJ; Johnstone RW PLoS Biol; 2010 Apr; 8(4):e1000361. PubMed ID: 20436908 [TBL] [Abstract][Full Text] [Related]
20. Characterization of interferon α and β receptor IFNAR1 and IFNAR2 expression and regulation in the uterine endometrium during the estrous cycle and pregnancy in pigs. Jang H; Choi Y; Yoo I; Han J; Kim M; Ka H Theriogenology; 2017 Jan; 88():166-173. PubMed ID: 27769575 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]